ArticleCancer medicine2022

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.

Shan-Shan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.